Literature DB >> 1992790

Importance of endothelium-derived nitric oxide in porcine coronary resistance arteries.

M Tschudi1, V Richard, F R Bühler, T F Lüscher.   

Abstract

Endothelial cells regulate vascular tone through the release of nitric oxide and other relaxing factors. The role of these substances was studied in isolated intramyocardial porcine coronary resistance arteries suspended in myographs for isometric tension recording. The inhibitor of nitric oxide formation NG-monomethyl-L-arginine (L-NMMA; 10(-7)-10(-4)M), but not D-NMMA, caused endothelium-dependent contractions that could be reversed by L-arginine but not by D-arginine. In preparations with endothelium, L-NMMA potentiated the contractions induced by acetylcholine and the relaxations to 3-morpholino-sydnonimine. Under both conditions, the effect of endothelial removal was slightly more pronounced than that of L-NMMA. Bradykinin, serotonin, and the alpha 2-adrenergic agonist clonidine evoked endothelium-dependent relaxations. L-NMMA as well as the inhibitor of guanylate cyclase methylene blue (10(-5) M) prevented the relaxations induced by clonidine, reduced those to serotonin, but hardly affected those to bradykinin. Thus, in porcine coronary resistance arteries, endothelium-derived nitric oxide is continuously produced from L-arginine. Endothelium-dependent relaxations to clonidine are fully mediated and those to serotonin partially mediated by nitric oxide; its release does not involve a Gi protein. An endothelium-derived relaxing factor different from nitric oxide must mediate the relaxations to bradykinin and contribute to those evoked by serotonin.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1992790     DOI: 10.1152/ajpheart.1991.260.1.H13

Source DB:  PubMed          Journal:  Am J Physiol        ISSN: 0002-9513


  16 in total

1.  Contribution of NO and cytochrome P450 to the vasodilator effect of bradykinin in the rat kidney.

Authors:  D Fulton; J C McGiff; J Quilley
Journal:  Br J Pharmacol       Date:  1992-11       Impact factor: 8.739

Review 2.  Coronary microcirculation: autoregulation and metabolic control.

Authors:  D V DeFily; W M Chilian
Journal:  Basic Res Cardiol       Date:  1995 Mar-Apr       Impact factor: 17.165

Review 3.  Sex hormones and vascular reactivity.

Authors:  S J Hutchison; K Sudhir; T M Chou; K Chatterjee
Journal:  Herz       Date:  1997-06       Impact factor: 1.443

Review 4.  Endogenous and exogenous nitrates and their role in myocardial ischaemia.

Authors:  T F Lüscher
Journal:  Br J Clin Pharmacol       Date:  1992       Impact factor: 4.335

5.  Nitric oxide activity in the human coronary circulation. Impact of risk factors for coronary atherosclerosis.

Authors:  A A Quyyumi; N Dakak; N P Andrews; S Husain; S Arora; D M Gilligan; J A Panza; R O Cannon
Journal:  J Clin Invest       Date:  1995-04       Impact factor: 14.808

6.  Regional coronary haemodynamic effects of two inhibitors of nitric oxide synthesis in anaesthetized, open-chest dogs.

Authors:  V Richard; A Berdeaux; C D la Rochelle; J F Giudicelli
Journal:  Br J Pharmacol       Date:  1991-09       Impact factor: 8.739

7.  Heterogeneity of muscarinic receptors in lamb isolated coronary resistance arteries.

Authors:  U Simonsen; D Prieto; L Rivera; M Hernández; M J Mulvany; A García-Sacristán
Journal:  Br J Pharmacol       Date:  1993-08       Impact factor: 8.739

8.  Cytochrome P450-dependent effects of bradykinin in the rat heart.

Authors:  D Fulton; K Mahboubi; J C McGiff; J Quilley
Journal:  Br J Pharmacol       Date:  1995-01       Impact factor: 8.739

9.  Endothelium-mediated coronary blood flow modulation in humans. Effects of age, atherosclerosis, hypercholesterolemia, and hypertension.

Authors:  A M Zeiher; H Drexler; B Saurbier; H Just
Journal:  J Clin Invest       Date:  1993-08       Impact factor: 14.808

10.  Role of K+ channels in the vasodilator response to bradykinin in the rat heart.

Authors:  D Fulton; J C McGiff; J Quilley
Journal:  Br J Pharmacol       Date:  1994-11       Impact factor: 8.739

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.